SCHEMBL3002832

SCHEMBL3002832

COc1ccccc1Cc1csc(N2CCC(S(=O)(=O)c3cc(Cl)ccc3Cl)CC2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.38
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
LMNA P02545 2/20 0.37
TSHR P16473 2/20 0.37
MAPT P10636 2/20 0.37
HTT P42858 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
RECQL P46063 1/20 0.36
DRD2 P14416 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3018934 0.94 DRD2 (0.40) TP53ALDH1A1KDM4EPOLBHPGD
SCHEMBL3012653 0.93 MEN1 (0.37) TP53ALDH1A1KDM4EMAPTMEN1
SCHEMBL3018577 0.92 CTSS (0.40) TP53ALDH1A1HPGDLMNATSHR
SCHEMBL2999638 0.90 TSHR (0.37) ALDH1A1RAB9ALMNATSHRMAPT
SCHEMBL3017937 0.90 TP53 (0.39) TP53ALDH1A1KDM4EPOLBHPGD
SCHEMBL3013781 0.90 TP53 (0.36) TP53ALDH1A1HPGDLMNATSHR
SCHEMBL3016184 0.90 SMN1; SMN2 (0.37) TP53ALDH1A1KDM4EPOLBHPGD
SCHEMBL3011166 0.89 MAPT (0.47) TP53ALDH1A1KDM4EPOLBHPGD
SCHEMBL3011644 0.89 MAPT (0.36) ALDH1A1KDM4EMAPTHTTMEN1
SCHEMBL3014184 0.89 RECQL (0.38) ALDH1A1POLBRAB9ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722681-B2 N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases NV REMYND (BE) 2014-05-13 US disclosed
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES NV REMYND (BE) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES SMN1; SMN2, HTT, SNCA TP53 2880/4885ALDH1A1 3510/4885KDM4E 4398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.